1. Home
  2. KYTX vs ACCD Comparison

KYTX vs ACCD Comparison

Compare KYTX & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • ACCD
  • Stock Information
  • Founded
  • KYTX 2018
  • ACCD 2007
  • Country
  • KYTX United States
  • ACCD United States
  • Employees
  • KYTX N/A
  • ACCD N/A
  • Industry
  • KYTX
  • ACCD Business Services
  • Sector
  • KYTX
  • ACCD Consumer Discretionary
  • Exchange
  • KYTX NYSE
  • ACCD Nasdaq
  • Market Cap
  • KYTX 242.1M
  • ACCD 281.1M
  • IPO Year
  • KYTX 2024
  • ACCD 2020
  • Fundamental
  • Price
  • KYTX $3.99
  • ACCD $3.71
  • Analyst Decision
  • KYTX Buy
  • ACCD Buy
  • Analyst Count
  • KYTX 5
  • ACCD 12
  • Target Price
  • KYTX $23.20
  • ACCD $9.04
  • AVG Volume (30 Days)
  • KYTX 248.8K
  • ACCD 1.3M
  • Earning Date
  • KYTX 11-13-2024
  • ACCD 01-06-2025
  • Dividend Yield
  • KYTX N/A
  • ACCD N/A
  • EPS Growth
  • KYTX N/A
  • ACCD N/A
  • EPS
  • KYTX N/A
  • ACCD N/A
  • Revenue
  • KYTX N/A
  • ACCD $441,028,000.00
  • Revenue This Year
  • KYTX N/A
  • ACCD $15.56
  • Revenue Next Year
  • KYTX N/A
  • ACCD $11.76
  • P/E Ratio
  • KYTX N/A
  • ACCD N/A
  • Revenue Growth
  • KYTX N/A
  • ACCD 16.04
  • 52 Week Low
  • KYTX $3.94
  • ACCD $3.08
  • 52 Week High
  • KYTX $30.60
  • ACCD $15.36
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 30.54
  • ACCD 57.22
  • Support Level
  • KYTX $3.94
  • ACCD $3.30
  • Resistance Level
  • KYTX $4.34
  • ACCD $3.80
  • Average True Range (ATR)
  • KYTX 0.38
  • ACCD 0.19
  • MACD
  • KYTX -0.10
  • ACCD 0.04
  • Stochastic Oscillator
  • KYTX 2.99
  • ACCD 87.50

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About ACCD Accolade Inc.

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Share on Social Networks: